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Abstract.  We describe the electron microscopic inves- 
tigation of purified U4/U6 snRNPs from human and 
murine cells. The U4/U6 snRNP exhibits two morpho- 
logical features, a main body ",,8 nm in diameter and 
a peripheral filamentous domain, 7-10  nm long. Two 
lines of evidence suggest that the peripheral domain 
may consist of RNA and to contain U6 RNA as well 
as the 5' portion of U4 RNA.  (a) Separation of the 
U4/U6 snRNA interaction regions from the core do- 
mains by site-directed cleavage of the U4 snRNA with 
RNase H gave filament-free, globular core snRNP 
structures.  (b) By immuno and DNA-hybridization EM, 
both the 5' end of U4 and the 3' end of U6 snRNA 
were located at the distal region of the filamentous do- 
main, furthest from the core. These results, together 
with our observation that the filamentous U4/U6 do- 
main is often Y shaped, correlate strikingly with the 
consensus secondary structure proposed by Brow and 
Guthrie (1988. Nature  (Lond.).  334:213-218),  where 
U4 and U6 snRNA are base paired in such a way 
that two U4/U6 helices together with a stem/loop of 
U4 snRNA make up a Y-shaped U4/U6 interaction 
domain. 
UKARYOTIC cells contain a number of small nuclear 
ribonucleoproteins  (snRNPs) t of the Sm class,  of 
which the principal  members  are snRNPs  U1,  U2, 
U4/U6, and U5. The snRNPs consist of either one (U1, U2, 
U5) or two (U4/U6) snRNA molecules and a set of polypep- 
tides, which fall into two general classes: the common and 
the particle-specific ones. The common proteins B', B, D, E, 
F, and G are bound to the so-called Sm-binding site or do- 
main A, a structural motif  that is shared by the snRNAs U1, 
U2, U4, and U5 (6, 26, 29). In addition to the core proteins, 
at least U1, U2, and the 20S U5 snRNP contain specific pro- 
teins (1, 27). Proteins specific to U4/U6 snRNP have as yet 
not been identified in metazoan cells. By EM it has recently 
been shown that the snRNP core structures of the snRNPs 
U1, U2,  and U5 are morphologically  very similar and can 
be described as a round body •8  nm in diameter. In addition 
to the core domain, snRNPs U1, U2, and 135 display periph- 
eral structures,  which arise  from the snRNP-specific pro- 
teins, that give each of  these snRNP species its characteristic 
shape (21, 22). 
The major snRNPs UI, U2, U4/U6, and U5 are essential 
trans-acting factors in the pre-mRNA splicing process both 
in human and in yeast. They assemble with a pre-mRNA and 
a number of  other proteins along an ordered pathway to form 
an active spliceosome (17, 19, 28, 33, 35). At an early stage 
of spliceosome assembly, U1  and U2 snRNPs interact di- 
rectly with the 5' splice site and the branch point,  respec- 
tively, and this  step is  followed by the integration  of the 
snRNPs U4/U6 and U5 into the spliceosome. While interac- 
1. Abbreviations used in this paper: EATC, Ehrlich ascites tumor cell; 
snRNP, small nuclear ribonucleoprotein. 
tion of U5 snRNP with the 3' splice site has been suggested 
(13), there is, as yet, no indication for a direct interaction be- 
tween U4/U6  snRNP  and the pre-mRNA.  In nuclear  ex- 
tracts, the snRNP U4/U6 and the 20S U5 snRNP form a 25S 
multi-snRNP complex which most likely represents an early 
spliceosome intermediate  (2,  14, 23). 
The exact role played by U4/U6 snRNP during splicing re- 
mains enigmatic. The U4/U6 snRNP displays several unique 
properties  as compared with the other major Sm snRNPs. 
The U6 snRNA is the most highly conserved spliceosomal 
snRNA (11) and is the only one that lacks the trimethylguano- 
sine (m3G) cap, instead,  it contains a "r-methyl phosphate 
group at its 5' end (34). Since U6 snRNA lacks the domain 
A,  the  association  of U6  snRNA with U4  snRNP  in the 
U4/U6  particle  appears  to be largely determined  by base 
pairing between U4 and U6 snRNAs (10, 20, 32). On the ba- 
sis of phylogenetic comparison  of U4 and U6 snRNA se- 
quences from a variety of organisms, a conserved secondary 
structure  model  has been proposed.  This consists of two 
intermolecular helices ~7 and 15 bp long, which are sepa- 
rated by an intramolecular  stem of U4 snRNA producing a 
Y-shaped structure (11, 19, 40). During splicing, the U4/U6 
snRNP appears to undergo a major conformational change 
prior to or concomitant with 5' splice site cleavage, measur- 
able as a weakening of  the U4/U6 interaction (4, 14, 24, 31). 
These data, together with the observation of the insertion of 
an intron into a highly conserved region of the S. pombe U6 
snRNA (36), led to the hypothesis that U6 functions as a 
catalytic element in the splicing reaction  (12, 18). In this 
view, the primary role of U4 snRNP would be to sequester 
a  catalytically  active domain  of U6 until  all  spliceosom- 
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spliceosome. 
To gain insight into the functional significance of the inter- 
action between U4 and U6 snRNAs during splicing, knowl- 
edge of  the three-dimensional structure of  the U4/U6 snRNP 
is essential. As a step in this direction, we have investigated 
purified U4/U6  snRNPs  at the ultrastructural level using 
EM.  The  U4/U6  snRNP exhibits two morphological fea- 
tures, a main body ~8 nm in diameter that resembles closely 
the core snRNP structure of snRNPs 131, U2, and U5 (21, 
22) and a peripheral filamentous domain that often exhibits 
a Y-shaped appearance. This Y-shaped filamentous domain 
contains distal from the core structure the 5' end of the U4 
snRNA and the 3' end of the U6 snRNA. This strongly sup- 
ports a proposed conserved U4/U6 secondary structure mod- 
el (11, 19, 40) that involves  a Y-shaped filamentous U4/U6 
interaction domain. 
Materials and Methods 
Preparation of U4/U6 snRNPs 
U4/U6 snRNPs were isolated from HeLa and Ehrlich ascites tumour cells 
(EATCs) as described in detail elsewhere (37). In summary, nuclear extracts 
prepared from HeLa cells according to Dignam et al. (15) or from EATC 
according to Zieve and Penman (39) were partially depleted of the snRNPs 
U1 and U2 by passage over an anti-m3G immuno-affinity  column. A sec- 
ond passage  over a same column followed by competitive  elution of the 
bound snRNPs with mTG (5) led to fractions highly enriched in U4/U6 
snRNPs. Further fractionation by ion-exchange chromatography on Mono Q 
(Pharmacia Fine Chemicals, Piscataway, NJ) using an ascending  KCI gra- 
dient (50 mM to  1 M) in elution buffer (20 mM Tris-HCl  at pH 7.5, 1.5 
mM MgC12, 0.5 mM PMSF, 0.5 mM DTT) yielded essentially pure U4/U6 
snRNPs.  The identity of the snRNA and protein constituents  was deter- 
mined by electrophorcsis,  as described by Bringrnann et al. (9). The final 
concentration  of the U4/U6 snRNPs from HeLa was 23/~g/ml, and that ob- 
tained from EATC was 272/zg/ml. 
Immunocomplex Formation 
HeLa U4/U6 snRNPs (6 #g) were allowed to react with 2.5/~g of monoclo- 
hal anti-m3G  IgG H20 (5) by incubation for 60 rain at 0*C  in 50 ~1 of 
buffer A, which consisted of 20 mM Tris-HCl (pH 7.9), 50 mM KCI, and 
15 mM MgCI2. Samples  for EM were prepared directly  from the incuba- 
tion mixture. 
Gradient Centrifugation 
Samples  were diluted to 100/~1 with buffer A and loaded onto a 5-20% 
glycerol gradient (1.3 ml) in buffer B (20 mM Hepes. KOH at pH 7.9, 150 
mM KCI, 3 mM MgC12). Centrifugation was performed for 5 h at 55,000 
rpm in a TLS-55 rotor (Beckman Instruments, Inc., Palo Alto, CA). The 
gradient was fractionated into 60-#1 portions starting from the bottom. 
Complex Formation between Streptavidin and 
the 3' End of the U6 snRNA 
EATC U4/U6 snRNPs (10/zg) were incubated together with 7/~g 5'-bio- 
tinylat~t DNA "U6-oligonucleotide"  in buffer A for 60 rain at 30*C. The 
oligonucleofide  (BioG-BioG-BioG-CGTTCACGAATTIV.d2GTGTC, where 
BioG  is  biotinylated  guanosine)  is complementary  to nueleotides 75-95 at  the 
3' end of U6 snRNA.  The oligonucleotide  was a kind gift from Dr. A. Bin- 
dereif (Berlin) and was synthesized  according to the protocol of Clontech 
Laboratories Inc. (Palo Alto, CA) using the Amino Modifier II and Biotin- 
X-NHS ester to incorporate three biotin-modified  guanosine residues at the 
5' end of the oligonucleotide.  After the addition of 160/~g streptavidin 
(Pierce Chemical Co., Rockford,  IL) and another incubation for 30 rain at 
30°C, the mixture was layered onto a 5-20% glycerol  gradient in buffer B 
containing 300 instead of 150 mM KCI. The gradient was centrifuged  and 
fractionated as described above. An oligonucleotide  containing one Biotin- 
11-dUMP at the 3' end (kindly provided by Drs. U. Albrecht and D. Schiim- 
pedi, Bern) was also initially used to label the U6 snRNA. With this oligo- 
nucleotide a lower rate of streptavidin complex formation was observed and 
not used further. 
Digestion of [74 snRNA with RNase H 
EATC U4/U6 snRNPs (10 #g) were  incubated together with 0.4 A260 U 
DNA "U4-oligonucleotide"  and 2 U of RNase H (Boehringer Mannheim 
Biochemicals,  Indianapolis,  IN) in a volume of 50 ttl in buffer C (20 mM 
Tris-HCl  at pH 7.5, 5 mM MgCI2, 200 mM KC1, 1 mM DTE) for 60 min 
at 30°C.  The oligonucleotide  (GGGTA~GTTTIV_.AATTAG) 
is complementary to nucleotides  58-84 of the U4 snRNA.  After dilution 
with buffer A, the mixture was centrifuged in a glycerol  gradient as de- 
scribed above. 
EM 
Negative staining with 2.5% uranyl formate was carried out by the double 
carbon film method as described by Kastner and Liihrmann  (21). The prepa- 
rations were examined under a Zeiss EM 109 electron microscope with an 
acceleration voltage  of 80 kV,  and electron micrographs were  taken at 
magnifications  between 85,000 and 140,000. 
Results 
U4/U6 snRNPs Contain a Globular and a b~lamentous 
Structural Domain 
Fig.  1 shows the snRNA and protein compositions of the 
purified human (HeLa) and murine (Ehrlich ascites tumour 
cell, EATC) U4/U6 snRNPs. Besides minor contaminations 
by U1 or U2 snRNA, the preparations contain only U4 and 
U6 snRNAs and the common proteins B' (HeLa only), B, D, 
E,  E  and G.  No U4/U6-specific proteins were detected in 
Figure 1.  Polypeptide and snRNA composition of U4/U6 snRNPs 
from EATC and HeLa ceils. (A and B) The snRNA was separated 
by electrophoresis on a  urea-polyacrylamide gel and made visible 
by silver staining. (C and D) The proteins were extracted with PCA 
before electrophoresis on a  4-20%  SDS-polyacrylarnide gel and 
stained with Coomassie blue. (A and C) snRNA and proteins, re- 
spectively, of U4/U6 snRNPs from EATC. (B and D) snRNA and 
proteins,  respectively,  of U4/U6  snRNPs  from  HeLa  cells.  The 
separation of the U6 snRNA into a double band in B, representing 
conformational variants, is due to a much longer running time than 
used for the electrophoresis in A. 
The Journal of Cell Biology. Volume 112, 1991  1066 Figure 2.  U4/U6 snRNPs negatively stained with uranyl formate. (A and B) General views of U4/U6 snRNPs purified from HeLa cells 
(A) and EATC (B). (C) Gallery of  representative images of U4/U6 snRNPs from EATC. The views have been rotated so that the filamentous 
domain is above the core in each case. The filamentous domains of the particles in each row show similar structural details: some filaments 
appear more diffuse (first row), while in others a Y-shaped structure  can be recognized (second tofifth row). One arm of this structure 
is always connected to the core domain and the second arm points more or less directly away from it, while, with respect to the second 
arm, the third arm points downwards (second row), upwards (third row), to the right (fourth row), or to the left (fij~h row). In areas of 
optimal contrast the Y-shaped structure is visible in about one-third of the images and rows three and four show examples of such predomi- 
nantly observed images. Bars,  I0 nm. 
these  preparations  (8).  The  U4/U6  snRNPs  used  in  this 
study are functionally active insofar that they are capable of 
restoring splicing activity when added alongside purified U1, 
U2, and U5 snRNPs to HeLa cell nuclear extracts that have 
been predepleted of their endogenous snRNPs by micrococ- 
cal nuclease digestion (37;  M.  Bach, data not shown). 
For electron microscopic investigations, the purified U4/ 
U6 snRNP particles were negatively contrasted with uranyl 
formate as described previously (21).  Fig. 2 A shows a gen- 
eral field of HeLa U4/U6 snRNPs. The snRNP particles are 
characterized by two morphological features. The main fea- 
ture is a round body, or core, ,,o8 nm in diameter. On close 
inspection of individual views, further structural details in 
the core can be recognized.  These are revealed by regions 
of high  stain  density  within  the  globular  domain.  Some- 
times, forms are seen with a line of stain that roughly bisects 
the round body. In regard to size, appearance, and fine struc- 
ture, this main body closely resembles the core snRNP parti- 
cles of the snRNPs U1, U2 and U5, that is, the snRNPs U1, 
U2,  and  U5  lacking  their  complement of snRNP-specific 
proteins (22). It is therefore likely that the round body of the 
U4/U6 snRNP particle also represents the core snRNP do- 
main of this snRNP, consisting of domain A  of U4 snRNA 
and the common proteins B' to G. 
The second feature that can be distinguished is a filamen- 
tous  structure  that protrudes  from the  core domain.  This 
filamentous  protrusion  regularly  appears  relatively  dark 
and,  for this  reason,  is often hard to distinguish  from the 
stain surrounding it. The contours of the U4/U6 snRNP par- 
ticle and its internal fine structure appear similar irrespective 
of whether the U4/U6 are taken from HeLa (Fig.  2 A) or 
from EATC (Fig. 2 B). The visibility of the filamentous pro- 
trusion varies greatly, on account of the poor contrast be- 
tween them and the background. On a single grid, the pro- 
trusions in some areas can be nearly invisible, while in other 
areas of the same grid they appear almost as clearly as the 
globular core-snRNP domains.  In  some instances,  "dumb 
bell-shaped" particles are also seen,  in which two globular 
bodies  ~8  nm  in  diameter appear to  be  connected  by  a 
filamentous structure 8-17 nm in length. While these struc- 
tures  could  be  interpreted  by  assuming  that  two  U4/U6 
monomers can dimerize by an association involving two dis- 
tal Y  arms, they are not considered further here. 
Upon closer examination,  the  more clearly visible fila- 
ments reveal fine structures that differ from one view to an- 
other but which follow certain reproducible patterns. Fig. 2 
C  contains  examples  of typical  U4/U6  snRNPs  at  high 
magnification. The first row shows U4/U6 snRNP particles 
as they appear most frequently; the filamentous structure is 
very diffuse, and at its base it appears up to 5 nm wide. The 
U4/U6 snRNP particles in the second row show very similar 
filaments, but on closer inspection these are seen to possess 
a well-defined fine structure. The 5-nm base consists of two 
thin,  elongated structures that join some 3-5 nm from the 
globular core domain. Each line has a diameter of ,x, 2 nm. 
The line running towards bottom left does not appear to be 
connected with the core domain. The branching point of the 
lines frequently  shows a  characteristic Y-like structure.  In 
the third, fourth, and fifth rows of Fig. 2  C, U4/U6 snRNP 
particles with more easily discernible Y-shaped domains are 
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Figure 3.  Model of the  sec- 
ondary  structure  of  U4/U6 
snRNA. The sequences of U4 
and U6 snRNA are shown in 
the consensus secondary struc- 
ture proposed by Guthrie and 
Patterson  (19).  In  addition, 
the regions complementary to 
the DNA-oligonucleotides used 
in  this  work  are  shown  by 
black  lines.  The  black  loz- 
enges on the U6 DNA oligonu- 
cleotide represent biotinylated 
guanosine residues. The single- 
stranded IhtAUUUUUGPu se- 
quence, together with the two 
flanking  hairpin  loops,  rep- 
resents the domain A (6). 
shown.  The arms of the Y-like domains are between 3 and 
6  nm in length, giving the Y  structure an overall length of 
some  10 nm. 
The Filamentous Protrusion Contains the 5' End of 
the U4 snRNA and the 3' End of the U6 snRNA 
If the U4/U6 secondary structure proposal which includes 
a Y-shaped U4/U6 interaction domain (11) is considered, the 
Y-shaped appearance of the filamentous structure in some of 
the U4/U6 electron micrographs (Fig. 2 C) suggests that this 
structural feature might consist of RNA and represent the do- 
main  in which the interaction between  U4  and  U6  takes 
place. 
To test this working hypothesis, we first  determined the 
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surface of the U4/U6 snRNP. For this purpose, we made im- 
munocomplexes between U4/U6 snRNPs and the m3G-spe- 
cific mAb H20 (5); these were then investigated under the 
electron microscope without further purification. Fig. 4 A 
shows a typical general view, in which free U4/U6 snRNPs 
and snRNP particles with an attached IgG molecule (marked 
by arrowheads) can be seen. More than 200 U4/U6 H20 im- 
munocomplexes with  recognizable filamentous  structures 
were examined.  The IgG antibodies can be recognized by 
their typical Y  shape, and they are appreciably larger than 
the filamentous U4/U6 domains. Fig. 4 B shows a selection 
of typical immunocomplexes. The antibody-binding site was 
always located in the filamentous domain, and in >90% of 
the complexes it was clearly separated from the core domain. 
Distances of  up to 8 nm were measured between the core and 
the antibody-binding site.  The observed position of the anti- 
body-binding site allows the conclusion that the m3G cap, 
and thus the 5' end of the U4 snRNA, lie in the filamentous 
domain and are clearly separated from the core. 
Next, we attempted to determine whether U6 snRNA was 
also contained in the filamentous protrusion. U6-specific an- 
tibodies were not available,  so we adopted a  different ap- 
proach (30) to this question: streptavidin was used to locate 
a biotinylated nucleotide complementary to the 3' end of the 
U6 snRNA. The 3' end of the U6 snRNA was chosen because 
(a) in earlier studies, it had been shown that the 3' end of U6 
snRNA is single stranded in the U4/U6 snRNP particle (3, 
4,  16, 38); and (b) according to Guthrie's consensus secon- 
dary structure model for U4/U6 snRNA,  the 3' end of the 
U6 snRNA is situated far from the core snRNP domain (11, 
19). Streptavidin is well suited for this electron microscopic 
analysis,  because with  its  diameter of ,,05 nm  it is  large 
enough to  be clearly recognizable in  the electron micro- 
scope, while its shape makes it clearly distinguishable from 
the large U4/U6 core domain. In addition, streptavidin does 
not bind to unlabeled U4/U6 snRNPs (data not shown). 
Purified U4/U6 snRNPs were incubated together with the 
U6  DNA  oligonucleotide.  This  oligonucleotide  is  com- 
plementary to nucleotides 78-95 of U6 snRNA and carries 
three biotinylated G nucleotides at its 5' end (Fig. 3). It hy- 
bridizes exclusively with the 3' end of U6 snRNA, and shows 
no interaction with any other part of this molecule or with 
U4 snRNA.  After the addition of an excess of streptavidin 
and brief incubation, the preparation was fraetionated on a 
glycerol gradient. The snRNPs in the various fractions of  the 
gradient were then examined under the electron microscope. 
Fig.  5  A  shows  a  general  field of a  fraction  containing 
U4/U6-streptavidin complexes, labeled with arrows. Beside 
these complexes, the fraction contains mainly oligomeric 
streptavidin aggregates (labeled with arrowheads), and occa- 
sional free U4/U6 snRNPs.  The binding site of the strep- 
tavidin molecules on the  U4/U6  snRNPs  is  clearly iden- 
tifiable in the filamentous domain, well separated from the 
core. This fact also aids the easy identification of these com- 
plexes, of which >100 were examined under the electron mi- 
croscope. 
Fig.  5  B  shows a  gallery of streptavidin-labeled U4/U6 
snRNPs.  The complexes are oriented such that the U4/U6 
core domains (the larger globular structure) are at the bot- 
tom and the streptavidin (the smaller, round structure) is at 
the top. The streptavidin binds to the filamentous domains, 
some 10 nm from the cores. In some of the complexes, the 
filamentous domain can be recognized as a  Y-shaped fine 
structure (Fig. 5 B, bottom row). In these cases, the strep- 
tavidin-binding site lies on one of the arms of  the Y structure 
that point away from the core domains. The 3' end of the U6 
snRNA thus resides on one of the distal arms of the Y struc- 
ture of the U4/U6 snRNPs, clearly removed from the core 
domain. 
As a third experimental demonstration that the filamen- 
tous domain consist of U4  and  U6  RNA,  we treated the 
U4/U6 snRNPs with RNase H and a DNA oligonucleotide 
complementary to the nucleotides 58 to 84 of the U4 snRNA 
(Fig. 3) so as to destroy specifically the 134 snRNA between 
domain A and the U6 snRNA interaction domain (see Fig. 
3). The conditions were chosen such that about one-quarter 
of  the U4 snRNA remained intact as determined by RNA gel 
electrophoresis  (not  shown).  The  residual  intact  U4/U6 
snRNPs served as an internal check on the visibility of the 
filamentous domains in a  given field. After treatment with 
RNase H, the products were fractionated by glycerol density 
gradient centrifugation, and the snRNA and protein content 
of the  fractions  was  analyzed.  While  the  intact  U4/U6 
Figure 4.  The binding of anti-mjG to U4/U6 snRNPs. (A) General view showing complexes visible after incubation of HeLa U4/U6 
snRNPs with monoclonal m3G-specific  IgG antibodies. Antibody-binding sites on the U4/U6 snRNPs are indicated by arrowheads. (B) 
Gallery of selected [U41U6.IgG] (two upper rows) and [U4/U6.IgG.U4/U6] complexes (/ast row) obtained with the anti-m3G antibody. 
The U4/U6 snRNPs in the complexes are oriented with the filamentous domains pointing upwards. The complex at the far right of each 
row is illustrated by an interpretative sketch. (C) Schematic drawing of anti-m3G IgG binding to the U4/U6 snRNP. The U4/U6 snRNA 
is shown by its secondary structure model and the core domain is indicated by the large circle. Bars, 10 nm. 
Kastner et al. Electron Microscopy of U4/U6  snRNPs  1069 Figure 5. The binding of an oligonucleotide complementary to the 3' end of U6 snRNA and its detection by streptavidin when bound to 
U4/U6 snRNPs. EATC U4/U6 snRNPs were first hybridized with the biotinylated DNA oligonucleotide complementary  to the 3' end of 
the U6 snRNA and then incubated with streptavidin. Complexes were separated from the excess of unbound streptavidin by gradient cen- 
trifugation. (A) General view of a fraction enriched in streptavidin-U4/U6 snRNP complexes. Arrows point to U4/U6 snRNP-bound strep- 
tavidin. Arrowheads mark streptavidin aggregates. (B) Gallery of selected U4/U6-streptavidin complexes. The U4/U6 snRNPs in the com- 
plexes are oriented with the filamentous domain pointing upwards. The snRNP core is the lower and the streptavidin is the upper globular 
structure.  The complex at the far right of each row is illustrated by an interpretative  drawing, (C) Model of streptavidin binding to the 
U4/U6 snRNP via the biotinylated DNA oligonucleotide complementary  to the 3' end of the U6 snRNA. The U4/U6 snRNP is shown 
as in Fig. 4 C. The streptavidin is indicated by a small circle (top left) and is connected to one of the biotin molecules (black lozenges) 
of the DNA oligonucleotide.  Bars,  10 nm. 
snRNPs sedimented at about 10S,  the S value of the frag- 
mented core U4 snRNPs, i.e., U4 RNPs that contained only 
the T-terminal half of U4 RNA together with the core pro- 
teins, was reduced by 2-3 U (7--8 S) (not shown). For com- 
parison, intact U4/U6 snRNPs that had not been treated with 
RNase H  were centrifuged and analyzed in the same way. 
The fractions from the glycerol density gradients were in- 
vestigated under the electron microscope. Fig. 6 B  shows a 
general view of the 7-8S snRNPs, i.e., fragmented core U4 
snRNPs. Round, globular structures can be seen. Closer ex- 
amination of these reveals fine-structural elements such as 
bisecting lines and a central dot. Outside the core domain, 
Figure 6. Electron micrographs of gradient fractions obtained after 
centrifugation  of native and U4 snRNA-cleaved U4/U6 snRNPs. 
Samples corresponding to the 7-8S regions of the glycerol gradient 
were negatively stained with uranyl formate. A shows the fractions 
of  U4/U6 snRNPs cleaved by RNase H and the U4-oligonucleotide. 
B shows the fractions  of native U4/U6 snRNPs.  Different times 
were used for adsorption of the particles to the carbon films, in or- 
der to obtain specimens  with roughly the same particle  density. 
Therefore, the number of particles seen on each micrograph is not 
proportional to the particle concentration in the respective gradient 
fraction.  Bar, 20 am. 
the vast majority of these particles show no further structure. 
However, in a few of them (indicated with arrowheads in Fig. 
6 A), the filamentous domains and the Y-shaped structures 
can be seen.  This confirms that these domains are indeed 
visible in principle in this experiment, so that they really are 
absent from most of the particles and not just invisible owing 
to  poor contrast.  For  comparison,  a  general  view of the 
7-8S fraction from the glycerol gradient with native U4/U6 
snRNPs  shows that U4/U6  snRNP particles with the  fila- 
mentous domain predominate (Fig. 6 B). The absence of the 
filamentous  domain  from  RNase'H-fragmented core  U4 
snRNPs provides independent confirmation of the hypothe- 
sis discussed above that the filamentous domain contains the 
5' portion of U4 RNA and the U6 RNA molecule base paired 
to the U4 RNA. 
Discussion 
According to the results from EM presented here, the iso- 
lated U4/U6 snRNP lacking U4/U6-specific proteins con- 
sists of two different structural domains, one globular and 
one filamentous. The globular domain is more or less spheri- 
cal and has a diameter of •8nm.  Frequently, a central dot 
or bisecting line can be seen.  The globular domain of the 
U4/U6 snRNPs resembles, in shape, size, and fine structure, 
the core particles of the snRNPs U1, U2, and U5 (22). Core 
particles are obtained by the removal of all particle-specific 
proteins until only the common proteins B-G are left. It is 
consistent with this that the globular structure is the core in 
U4/U6 snRNP as well. 
The filamentous domain of the U4/U6 snRNP proceeds 
out of the core domain and is up to 10 nm long. It frequently 
possesses a Y-shaped fine structure, in which one ann is al- 
ways connected to the core. The other snRNPs U1, U2, and 
U5 also show other domains in addition to the round core, 
for example, elongated protrusions (21) or more globular ex- 
tensions (22). In earlier work, we were able to show by immu- 
noelectron microscopy that these additional domains consist 
of snRNP-specific proteins (22; Kastner, B.,  U. Kornstadt, 
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was therefore surprising at first that-U4/U6  snRNPs also 
show a further structure, the filamentous domain, even though 
these snRNPs do not contain specific proteins. We therefore 
pursued the possibility that these filamentous structures con- 
sisted solely of snRNA, as snRNA is the only component of 
U4/U6 snRNP that is specific for this particle only. 
Three lines of evidence show clearly that the filamentous 
extension represents part of U4 and U6 snRNA. (a) Separa- 
tion of the U4/U6 snRNA interaction regions from the core 
domains by cleavage of the U4 snRNA with RNase H gave 
filament-free, globular  core  snRNP  structures. (b)  Anti- 
m3G antibodies bind to the end of the filamentous domains 
furthest from the core, showing that the 5' terminus of the 
U4 snRNA must lie here. (c) Hybridization with a biotin- 
labeled DNA-oligonucleotide complementary to the 3' end 
of the U6 snRNA, and subsequent electron-microscopic lo- 
calization of streptavidin bound to the biotin, showed that the 
3' end of the U6 snRNA is also located in the very distal re- 
gion of the filamentous structure. 
The findings (a) that the 3' end of U6 and the 5' end of U4 
are in close proximity to each other at the tip of the filamen- 
tous domain and (b) that this domain is often Y-shaped are 
in striking agreement with the secondary structure proposed 
by Brow and Guthrie (11) and Zucker-Aprison et al.  (40), 
where U4 and U6 snRNA are base paired in such a way that 
two U4/U6 helices together with a stem/loop of U4 snRNA 
make up a Y-shaped U4/U6 interaction domain. Moreover, 
if A-form RNA-helices are assumed, a width of 2 nm and a 
length of  2--4 nm is expected for the double helical stems (7). 
This is in reasonable agreement with the dimensions ob- 
served for the Y-structure,  where the arms are 2 nm thick and 
3-6 nm long. 
Such a two-domain structure of U4/U6 would imply that 
the major part of the snRNAs in this particle is completely 
unprotected. This agrees with the results of  published studies 
of nuclease digestion of U4/U6 RNPs in solution, demon- 
strating that U6 RNA and the 5' half of U4 RNA are vulnera- 
ble to attack by RNase (3, 16, 25, 26). It is further significant 
that, after digestion with RNase H  and the oligonucleotide 
complementary to U4 snRNA, the filamentous domain can 
no longer be seen, that is, the U6 snRNA dissociates to- 
gether with the 5'-terminal part of U4 snRNA. This means 
that the U6 snRNA in the isolated U4/U6 snRNP monomer 
is associated principally by base pairing, while the core pro- 
teins do not make any important contribution to the stability 
of this complex (38). 
Recent evidence suggests that in nuclear extracts U4/U6 
snRNP  may  interact  with  U5  snRNP  and  form  a  25S 
[U4/U6. U5] tri-snRNP (2,  14, 23).  Though it has not yet 
been proved it is likely that the tri-snRNP complex repre- 
sents an early spliceosome intermediate that binds to pre- 
spliceosomes as such. While we have observed the Y-shaped 
filamentous structure in the purified U4/U6 snRNP, it may 
be asked whether this structure is functionally meaningful, 
i.e., whether it is preserved in the [U4/U6. U5] tri-snRNP 
complex. While at present we have no direct proof for this, 
there are strong arguments in favor of it. We have shown re- 
cently that U4/U6 snRNPs purified according to the same 
protocol as the particles used in this study are functionally 
active, i.e., they restore splicing activity when added along- 
side purified U1, U2, and U5 snRNPs to a HeLa cell nuclear 
extract depleted of the endogenous snRNPs by prior treat- 
ment with micrococcal nuclease (37). This indicates further 
that the purified U4/U6 snRNPs may readily interact with 
U5  snRNP and additional proteins of the nuclear extract 
needed for stable [U4/U6 • U5] tri-snRNP complex formation 
(Behrens, S., and R. Liihrmann, manuscript submitted for 
publication). This would not be expected if the peripheral 
Y-shaped domain observed in the purified U4/U6  snRNP 
(this paper) were to represent an artifact arising from the 
purification method. 
The structure of U4/U6 snRNPs as presented here is com- 
patible with the proposal that U6 snRNA may play a part in 
the catalysis of splicing of pre-mRNA.  In this model, U4 
snRNP could be considered as an snRNP particle delivering 
U6 snRNA to the site of action inside the spliceosome (12). 
In U4/U6 snRNP, the presumed catalytic snRNA is found, 
bound by base pairing to the U4 snRNA, stretched out, and 
at a distance from the bulky core snRNP region. This posi- 
tioning would make easier the approach of the U6 snRNA 
to the catalytic center of the spliceosome. The sequences ex- 
posed on isolated U4/U6  snRNPs would consequently be 
within the interior of the spliceosome and thereby protected. 
This is  supported by oligonucleotide-binding experiments 
(4): most of the regions of U4 and U6 snRNAs that in free 
U4/U6 are accessible for the binding of oligonucleotides ap- 
pear to be blocked in the spliceosome. As U4/U6 snRNP 
most probably becomes integrated into the spliceosome in 
the  form of a  25S  [U4/U6.U5]  tri-snRNP  complex  (see 
above), it will be important to investigate whether the Y-shaped 
domain of U4/U6 snRNP is still exposed at the surface of 
the tri-snRNP complex or already shielded by the interaction 
with the protein-rich U5 snRNP. 
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